CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Argentina

Researchmoz added Most up-to-date research on "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Argentina" to its huge collection of research reports. An insight on the important factors and trends influencing the market.
The industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Argentina". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Argentina. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

Get a Sample PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=1375917

Argentinas population grew from 40.13 million in 2009 to 43.60 million in 2016, mainly due to the increase in the life expectancy. The value of the pharmaceuticals market increased from $3.33 billion in 2009 to $6.37 billion in 2016 at a Compound Annual Growth Rate (CAGR) of 9.7%, and this value is expected to increase further from $6.99 billion in 2017 to $10.13 billion in 2021 at a CAGR of 10%. The medical device market was worth $1.32 billion in 2016 and is projected to reach $1.71 billion by 2021 at a CAGR of 5%.

These positive growth trends can be primarily attributed to
- An increasingly elderly population
- Government initiatives

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Argentina, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Roemmers, Bago, Gador, Bayer and Pfizer; and of major players in the medical device market: Sonova, Siemens Healthineers, GN Hearing, Cochlear and William Demant Holding
- An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the countrys healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the countrys political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Argentinas healthcare market

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/countryfocus-healthcare-regulatory-and-reimbursement-landscape-argentina-report.html/toc

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Argentinas healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Argentinas healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

For More Reports Visit @ http://marketresearchlatestreports.blogspot.com/

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Egypt | Latest Research Report

Researchmoz added Most up-to-date research on "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Egypt" to its huge collection of research reports.

Latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Egypt". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Egypt. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Egypt. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1476972

In 2016, Egypt population was approximately at 90.2 million. Egypt has the largest pharmaceutical manufacturing base in the Middle East and North Africa (MENA) region, representing around 30% of the regional market. Its pharmaceutical market was worth $2.31 billion in 2009 and an estimated $5.43 billion in 2016, having grown at a Compound Annual Growth Rate (CAGR) of 14.1%. The market is estimated to reach $10.50 billion in 2021. The Egyptian medical device market was valued at $0.70 billion in 2009 and is one of the growing industries in the healthcare sector, due to the aging population and consequent increase in demand for healthcare products and services. It grew to $0.95 billion at a CAGR of 4.2% between 2009 and 2016 and is forecast to reach $1.23 billion in 2021. The segments expected to experience high growth are cardiovascular devices, orthopedic device, drug delivery devices, in vitro diagnostics and healthcare IT.

These positive trends can primarily be attributed to -
- Government initiatives to develop and modernize government hospitals and therapeutic centres in various parts of the country
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Egypt, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (GSK, Novartis, Sanofi, Egyptian International Pharmaceutical Industries Company (EIPICO) and South Egypt Drug Industries Company (SEDICO))
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Egyptian healthcare market

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/countryfocus-healthcare-regulatory-and-reimbursement-landscape-egypt-report.html/toc

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Egyptian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Egyptian healthcare market 

Vietnam Pharmaceutical Market Is Expected To Reach $8 Billion By 2020 At A Projected Compound Annual Growth Rate (CAGR) Of 15.4%

Researchmoz added Most up-to-date research on "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam" to its huge collection of research reports.

The industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Vietnam. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Vietnam, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=208073

In 2013, Vietnams population stood at 89.7 million, an increase from 85.1 million in 2008 due to the high birth rate and low mortality rate. The countrys pharmaceutical market was estimated to have been worth $2.9 billion in 2013 and is expected to reach $8 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 15.4%. According to an EU Economic and Commercial Counsellor (EUECC) report in 2011, Vietnams medical device market was estimated at approximately $220m in 2010 and is expected to grow at a CAGR of 10% to over $350m by 2015.

The positive trends in Vietnams healthcare market can primarily be attributed to
Increasing coverage of healthcare insurance
Government initiatives to improve healthcare facilities

Scope

This report provides information on the healthcare, regulatory, and reimbursement landscape in the Vietnam, including the following
Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, GlaxoSmithKline, AstraZeneca, Novartis and DHG Pharmaceutical JSC
An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices
Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the healthcare market

Browse Detail Report With Full TOC @ http://www.researchmoz.us/countryfocus-healthcare-regulatory-and-reimbursement-landscape-vietnam-report.html

Reasons to buy

The report will enhance your decision-making capability by allowing you to
Develop business strategies through an understanding of the trends shaping and driving the healthcare market
Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors
Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership
Identify, understand and capitalize on the opportunities and challenges in the healthcare market

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=208073